"cGAs, Trex1 and type 1 Interferons -- Oh my! New insights into the immunological pathogenesis of lupus." Will focus on the clinical presentations of Cutaneous Lupus Erythematosus, the risk of concomitant Systemic Lupus Erythematosus, and delve into the current understanding of the pathophysiology of lupus.
Recognize the clinical presentations of Cutaneous Lupus Erythematosus (CLE)
Recognize that different CLE subtypes have differing risk of Systemic Lupus Erythematosus (SLE) development
Explain the current understanding of the pathophysiology of CLE
Identify characteristic auto-antibodies seen in CLE, SLE, drug induced SLE, drug induced CLE and the sensitivities and specificities of these auto-antibodies
Associate Professor of Dermatology, Dermatology Residency Program Director,
You must be logged in and own this session in order to